Such a phenotype was not significant in the PRL2-KO;PTEN HET animals, implying a role for PRL2 inhibition in the reduction of AML phenotypes in these animals and a possible explanation for the increase in survival time. The gene discussed is PTP4A2; the disease is acute myeloid leukemia.